Laboratory of Cell Signaling, Graduate School of Pharmaceutical Sciences, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Cell Signal Unit, Okinawa Institute of Science and Technology Graduate University, 1919-1 Tancha, Onna, Okinawa 904-0495, Japan.
J Biol Chem. 2020 Apr 24;295(17):5588-5601. doi: 10.1074/jbc.RA119.011508. Epub 2020 Mar 6.
Accumulating evidence suggests that brown adipose tissue (BAT) is a potential therapeutic target for managing obesity and related diseases. PGAM family member 5, mitochondrial serine/threonine protein phosphatase (PGAM5), is a protein phosphatase that resides in the mitochondria and regulates many biological processes, including cell death, mitophagy, and immune responses. Because BAT is a mitochondria-rich tissue, we have hypothesized that PGAM5 has a physiological function in BAT. We previously reported that PGAM5-knockout (KO) mice are resistant to severe metabolic stress. Importantly, lipid accumulation is suppressed in PGAM5-KO BAT, even under unstressed conditions, raising the possibility that PGAM5 deficiency stimulates lipid consumption. However, the mechanism underlying this observation is undetermined. Here, using an array of biochemical approaches, including quantitative RT-PCR, immunoblotting, and oxygen consumption assays, we show that PGAM5 negatively regulates energy expenditure in brown adipocytes. We found that PGAM5-KO brown adipocytes have an enhanced oxygen consumption rate and increased expression of uncoupling protein 1 (UCP1), a protein that increases energy consumption in the mitochondria. Mechanistically, we found that PGAM5 phosphatase activity and intramembrane cleavage are required for suppression of UCP1 activity. Furthermore, utilizing a genome-wide siRNA screen in HeLa cells to search for regulators of PGAM5 cleavage, we identified a set of candidate genes, including phosphatidylserine decarboxylase (), which catalyzes the formation of phosphatidylethanolamine at the mitochondrial membrane. Taken together, these results indicate that PGAM5 suppresses mitochondrial energy expenditure by down-regulating UCP1 expression in brown adipocytes and that its phosphatase activity and intramembrane cleavage are required for UCP1 suppression.
越来越多的证据表明,棕色脂肪组织(BAT)是治疗肥胖症和相关疾病的潜在治疗靶点。磷酸甘油酸变位酶家族成员 5,线粒体丝氨酸/苏氨酸蛋白磷酸酶(PGAM5),是一种位于线粒体中的蛋白磷酸酶,调节许多生物学过程,包括细胞死亡、线粒体自噬和免疫反应。由于 BAT 是一种富含线粒体的组织,我们假设 PGAM5 在 BAT 中有生理功能。我们之前报道过,PGAM5 敲除(KO)小鼠对严重代谢应激具有抗性。重要的是,PGAM5-KO BAT 中的脂质积累受到抑制,即使在非应激条件下,这增加了 PGAM5 缺乏刺激脂质消耗的可能性。然而,这种观察结果的机制尚不清楚。在这里,我们使用一系列生化方法,包括定量 RT-PCR、免疫印迹和耗氧量测定,表明 PGAM5 负调控棕色脂肪细胞的能量消耗。我们发现 PGAM5-KO 棕色脂肪细胞的耗氧量增加,解偶联蛋白 1(UCP1)的表达增加,UCP1 是一种增加线粒体能量消耗的蛋白质。从机制上讲,我们发现 PGAM5 磷酸酶活性和内膜切割对于抑制 UCP1 活性是必需的。此外,我们利用 HeLa 细胞中的全基因组 siRNA 筛选来寻找 PGAM5 切割的调节剂,鉴定出一组候选基因,包括磷脂酰丝氨酸脱羧酶(),它在线粒体膜上催化磷脂酰乙醇胺的形成。总之,这些结果表明,PGAM5 通过下调棕色脂肪细胞中 UCP1 的表达来抑制线粒体能量消耗,其磷酸酶活性和内膜切割对于抑制 UCP1 是必需的。